Dr. Eric Rivera Guevarez , MD
General Practice • Morovis, PR
5 Calle Patron
Morovis, PR 006873012
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Eric Rivera Guevarez is listed in NPPES under General Practice.
-
NPI assigned on October 4, 2006; this date does not establish years in practice.
-
Published CMS data list 4,077 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Simvastatin — 415 prescription fills, including refills.
- Losartan Potassium — 312 prescription fills, including refills.
- Atorvastatin Calcium — 262 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 73 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under General Practice in Morovis, PR (2024, 13 clinicians with data). Median for this group: 4,077. Middle half: 441 to 7,393.
More Part D prescriptions than 70% of clinicians listed under General Practice in Puerto Rico (2024, 2,628 clinicians with data). Median for this group: 1,253. Middle half: 239 to 5,097.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 4,360 in 2020 to 4,077 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
5 Calle Patron
Morovis, PR 006873012
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
10,126 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$142,153 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $15.52 in 2022
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2022.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Rivera Guevarez has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Rivera Guevarez as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Morovis and Puerto Rico
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under General Practice in Morovis, PR (2024, 13 clinicians with data). Median for this group: 4,077. Middle half: 441 to 7,393.
More Part D prescriptions than 70% of clinicians listed under General Practice in Puerto Rico (2024, 2,628 clinicians with data). Median for this group: 1,253. Middle half: 239 to 5,097.
Part D drug cost
Close to the middle for clinicians listed under General Practice in Morovis, PR (2024, 13 clinicians with data). Median for this group: $142,153. Middle half: $6,993 to $402,123.
A higher Part D drug cost than 65% of clinicians listed under General Practice in Puerto Rico (2024, 2,628 clinicians with data). Median for this group: $34,007. Middle half: $2,958 to $213,188.
16 active clinicians are listed under General Practice with a practice address in Morovis, PR (4,196 in Puerto Rico).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Morovis
0% of these 16 clinicians have the CMS telehealth indicator.
25% of these 16 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 4,360 in 2020 and 4,077 in 2024.
- 2020: 4,360
- 2021: 4,342
- 2022: 4,427
- 2023: 4,112
- 2024: 4,077
-
30-day fills
30-day fills stayed about the same: 10,124 in 2020 and 10,126 in 2024.
- 2020: 10,124
- 2021: 10,143
- 2022: 10,388
- 2023: 9,913
- 2024: 10,126
-
Part D drug cost
Part D drug cost stayed about the same: $142,612 in 2020 and $142,153 in 2024.
- 2020: $142,612
- 2021: $155,130
- 2022: $176,614
- 2023: $162,953
- 2024: $142,153
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $20.07 in 2019 to $15.52 in 2022.
- 2019: $20.07
- 2022: $15.52
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2022), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2022 (payments made January 1 – December 31, 2022): fewer than 11 records totaling $15.52.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
TRULICITY | General | $15.52 |
Source: CMS Open Payments, program year 2022, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Simvastatin | Simvastatin | 415 | 35,592 | $4,268.57 | 120 |
| Losartan Potassium | Losartan Potassium | 312 | 26,460 | $4,692.80 | 90 |
| Atorvastatin Calcium | Atorvastatin Calcium | 262 | 22,380 | $3,875.95 | 81 |
| Omeprazole | Omeprazole | 210 | 12,090 | $1,799.38 | 57 |
| Metformin Hcl | Metformin Hcl | 206 | 17,820 | $1,528.43 | 58 |
| Amlodipine Besylate | Amlodipine Besylate | 190 | 15,000 | $1,261.52 | 54 |
| Hydrochlorothiazide | Hydrochlorothiazide | 151 | 12,150 | $722.13 | 42 |
| Gabapentin | Gabapentin | 125 | 9,994 | $2,660.69 | 48 |
| Synthroid | Levothyroxine Sodium | 102 | 8,160 | $12,836.20 | 30 |
| Lisinopril | Lisinopril | 101 | 8,520 | $754.07 | 34 |
| Alendronate Sodium | Alendronate Sodium | 98 | 7,908 | $1,053.66 | 29 |
| Glimepiride | Glimepiride | 98 | 8,340 | $1,687.46 | 31 |
| Levothyroxine Sodium | Levothyroxine Sodium | 82 | 7,140 | $1,481.30 | 29 |
| Glipizide | Glipizide | 81 | 7,230 | $2,871.67 | 22 |
| Metoprolol Succinate | Metoprolol Succinate | 78 | 6,240 | $1,408.09 | 31 |
| Azithromycin | Azithromycin | 72 | 216 | $499.23 | 59 |
| Diclofenac Potassium | Diclofenac Potassium | 66 | 1,995 | $1,884.21 | 42 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 60 | 5,202 | $1,497.08 | 19 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 59 | 4,530 | $1,043.40 | 18 |
| Tamsulosin Hcl | Tamsulosin Hcl | 58 | 4,598 | $858.76 | 21 |
| Fenofibric Acid | Fenofibric Acid (Choline) | 58 | 5,160 | $4,453.74 | 20 |
| Meloxicam | Meloxicam | 51 | 1,890 | $258.12 | 32 |
| Famotidine | Famotidine | 49 | 3,090 | $442.68 | 21 |
| Fosinopril Sodium | Fosinopril Sodium | 47 | 4,050 | $1,586.43 | 14 |
| Pantoprazole Sodium | Pantoprazole Sodium | 44 | 2,751 | $639.10 | 13 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - GENERAL PRACTICE
I20110420000250
PR
3870778756
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
NPI status registered as active in NPPES database
Registered at 5 CALLE PATRON, MOROVIS, PR 006873012 (Tel: 7878625628)
Registered at 5 CALLE PATRON, MOROVIS, PR 006873012 (Tel: 7878625628)
Recorded as ERIC RIVERA GUEVAREZ, M.D.
General Practice (license number reported to NPPES: PR 11500)
NPI status registered as active in NPPES database
Registered at 5 CALLE PATRON, MOROVIS, PR 006873012 (Tel: 7878625628)
Registered at 5 CALLE PATRON, MOROVIS, PR 006873012 (Tel: 7878625628)
Recorded as ERIC GUEVAREZ, M.D.
General Practice (license number reported to NPPES: PR 11500)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other General Practices in Morovis
- Dr. Angel Guerrero Perez, MD
- Dr. Sherly Nevarez Martinez, MD
- Dr. Laura Caceres Charneco, MD
- Dr. Carlos Pentzke-Chamorro, MD
- Dr. Francisco Madera Liranzo, MD
- Dr. Gustavo Albizu, MD
Mailing Address
5 Calle Patron
Morovis, PR 006873012
Phone: 7878625628